Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference2%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.4%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding MIW815 (ADU-S100) and its clinical trial parameters, while a new version number has been added.SummaryDifference16%
Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.